Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06547710
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-07
Brief Title:
Primary Tumor Resection for M1a Stage Lung Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Primary Tumor Resection for M1a Stage Lung Cancer With Occult Pleural Dissemination Discovered During Surgery a Prospective Single-arm Multi-center Phase Ⅱ Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECTOP-1023
Brief Summary:
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project ECTOP numbered as ECTOP-1023 This study aims to explore the safety and efficacy of primary lesion resection in the treatment of M1a stage lung cancer with pleural dissemination found during surgery and to more accurately evaluate whether primary lesion resection can improve the OS and quality of life of the corresponding patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None